Recently, there has been an increasing focus on the pursuit of targets considered to be less
druggable that offer potential for development of promising new therapeutic agents for the …

Introduction: Currently, direct-acting antivirals (DAAs) are considered the ideal choice for the
treatment of chronic HCV patients due to their proven efficacy (SVR> 90%), and minimal …

Chronic hepatitis C virus (HCV) infection is associated with altered metabolism, including
dyslipidemia and insulin resistance. These contribute to disease progression and influences …

Patients with Crohn's disease (CD) are at a considerable risk for intestinal surgery.
Approximately 25% of patients with CD will undergo an intestinal resection within 10 years …

The occurrence of hepatocellular carcinoma (HCC) is one of the most serious complications
of hepatitis C virus (HCV) infection. Recently, effective antiviral medications have made …

Background: A large Egyptian treatment program for HCV was launched in2014 after the
introduction of direct-acting antiviral agents (DAAs). This program depended mainly on …

Hepatitis C virus (HCV) infection is one of the most common causes of liver pathology. It is a
major etiological factor of continuous liver injury by triggering an uncontrolled inflammatory …

Background & Aims Although treatment of hepatitis C virus (HCV) and HCV-genotype-4
(GT4) has become very effective, it remains very expensive, and affordable options are …

Background/Aims There is less data regarding the changes in body mass index (BMI) after
treating hepatitis C virus (HCV) patients with new direct-acting antiviral agents (DAAs). This …

Background It is well documented that Egypt has the highest prevalence of hepatitis C virus
(HCV) infection in the world. The recent development of highly effective direct acting antiviral …